H. Rothe

2.6k total citations
49 papers, 1.6k citations indexed

About

H. Rothe is a scholar working on Genetics, Surgery and Immunology. According to data from OpenAlex, H. Rothe has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 10 papers in Surgery and 10 papers in Immunology. Recurrent topics in H. Rothe's work include Diabetes and associated disorders (16 papers), Parathyroid Disorders and Treatments (8 papers) and Contact Dermatitis and Allergies (7 papers). H. Rothe is often cited by papers focused on Diabetes and associated disorders (16 papers), Parathyroid Disorders and Treatments (8 papers) and Contact Dermatitis and Allergies (7 papers). H. Rothe collaborates with scholars based in Germany, United Kingdom and United States. H. Rothe's co-authors include Hubert Kolb, H Kolb, Stéphan Martin, N G Copeland, Nancy A. Jenkins, Markus Ketteler, Karin Fehsel, Klaus Rettinger, Werner Schuh and Rolf Fautz and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

H. Rothe

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Rothe Germany 24 417 407 304 288 224 49 1.6k
A. J. G. Swaak Netherlands 25 121 0.3× 426 1.0× 463 1.5× 154 0.5× 151 0.7× 65 2.5k
Diana Teti Italy 27 173 0.4× 334 0.8× 944 3.1× 150 0.5× 58 0.3× 66 1.9k
Nam Hee Won South Korea 23 89 0.2× 739 1.8× 705 2.3× 209 0.7× 258 1.2× 59 2.3k
Ping Xie United States 20 59 0.1× 191 0.5× 650 2.1× 200 0.7× 320 1.4× 46 1.7k
Edi Levi United States 28 154 0.4× 219 0.5× 1.2k 3.8× 557 1.9× 33 0.1× 105 2.9k
Kirstin Atrott Switzerland 21 272 0.7× 493 1.2× 913 3.0× 230 0.8× 59 0.3× 48 1.6k
Lei Yin China 19 109 0.3× 84 0.2× 320 1.1× 57 0.2× 65 0.3× 64 1.1k
Joëlle Morin France 16 334 0.8× 429 1.1× 617 2.0× 306 1.1× 14 0.1× 47 1.5k
Liang Guo China 23 86 0.2× 132 0.3× 543 1.8× 198 0.7× 28 0.1× 116 1.8k

Countries citing papers authored by H. Rothe

Since Specialization
Citations

This map shows the geographic impact of H. Rothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Rothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Rothe more than expected).

Fields of papers citing papers by H. Rothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Rothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Rothe. The network helps show where H. Rothe may publish in the future.

Co-authorship network of co-authors of H. Rothe

This figure shows the co-authorship network connecting the top 25 collaborators of H. Rothe. A scholar is included among the top collaborators of H. Rothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Rothe. H. Rothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savige, Judy, Alessandra Renieri, Elisabet Ars, et al.. (2022). Digenic Alport Syndrome. Clinical Journal of the American Society of Nephrology. 17(11). 1697–1706. 27 indexed citations
2.
Rothe, H., et al.. (2021). Epitheloides Angiomyolipom der Niere nach stattgehabtem malignem Melanom. Der Urologe. 61(2). 183–186. 1 indexed citations
4.
Jacques, Carine, Andreas Schepky, Richard Cubberley, et al.. (2016). Comparison of protocols for measuring cosmetic ingredient distribution in human and pig skin. Toxicology in Vitro. 34. 153–160. 32 indexed citations
5.
Rothe, H.. (2012). Shedding new light on vasculitis: how the LAMP story unfolded. Journal of Nephrology. 25(5). 636–643.
6.
Rothe, H., et al.. (2011). Special aspects of cosmetic spray safety evaluations: Principles on inhalation risk assessment. Toxicology Letters. 205(2). 97–104. 180 indexed citations
7.
Reyes, Marcela, H. Rothe, Pamela Mattar, Warren Shapiro, & Mariana Cifuentes. (2011). Antilipolytic effect of calcimimetics depends on the allelic variant of calcium-sensing receptor gene polymorphism rs1042636 (Arg990Gly). European Journal of Human Genetics. 20(4). 480–482. 8 indexed citations
8.
Ketteler, Markus, H. Rothe, Thilo Krüger, Patrick Biggar, & Georg Schlieper. (2011). Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nature Reviews Nephrology. 7(9). 509–516. 57 indexed citations
9.
Goebel, Carsten, Pieter‐Jan Coenraads, H. Rothe, et al.. (2010). Elicitation of the immune response top-phenylenediamine in allergic patients: the role of dose and exposure time. British Journal of Dermatology. 163(6). 1205–1211. 23 indexed citations
10.
Rothe, H., et al.. (2005). Calcium-sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl. Pharmacogenetics and Genomics. 15(1). 29–34. 29 indexed citations
11.
Schloot, Nanette C., Pejman Hanifi-Moghaddam, Carsten Goebel, et al.. (2002). Serum IFN‐γ and IL‐10 levels are associated with disease progression in non‐obese diabetic mice. Diabetes/Metabolism Research and Reviews. 18(1). 64–70. 52 indexed citations
12.
Rothe, H. & Hubert Kolb. (1999). Strategies of protection from nitric oxide toxicity in islet inflammation. Journal of Molecular Medicine. 77(1). 40–44. 20 indexed citations
13.
Martin, Stéphan, et al.. (1998). Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia. 41(11). 1298–1303. 30 indexed citations
14.
Rothe, H., R M O'Hara, Stéphan Martin, & Hubert Kolb. (1997). Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40) 2. Diabetologia. 40(6). 641–646. 71 indexed citations
15.
Rothe, H., Nancy A. Jenkins, N G Copeland, & H Kolb. (1997). Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.. Journal of Clinical Investigation. 99(3). 469–474. 145 indexed citations
16.
Rothe, H., Gabriel D. Bossé, Hans Fischer, & Hubert Kolb. (1996). Generation and Characterization of Inducible Nitric Oxide Synthase Deficient Macrophage Cell Lines. Biological Chemistry Hoppe-Seyler. 377(4). 227–232. 8 indexed citations
17.
Gosling, Peter, et al.. (1995). Serum Copper and Zinc Concentrations in Patients with Burns in Relation to Burn Surface Area. Journal of Burn Care & Rehabilitation. 16(5). 481–486. 26 indexed citations
18.
Rothe, H., Ulrich F. Schade, Rainer Kleemann, et al.. (1994). Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia. 37(11). 1154–1158. 101 indexed citations
19.
Burkart, Volker, et al.. (1993). Oxygen Radical Production is Increased in Macrophages from Diabetes Prone Bb Rats. Autoimmunity. 15(2). 93–98. 28 indexed citations
20.
Suschek, Christoph V., H. Rothe, Karin Fehsel, Jürgen Enczmann, & Victoria Kolb-Bachofen. (1993). Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma.. The Journal of Immunology. 151(6). 3283–3291. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026